Status:
TERMINATED
Scripps Digital Diabetes: Cloud-Based Continuous Glucose Monitoring (CB CGM)
Lead Sponsor:
Scripps Whittier Diabetes Institute
Collaborating Sponsors:
DexCom, Inc.
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
Individuals with diabetes in the hospital often experience poor glycemic control, which places them at greater risk for infection, neurological and cardiac complications, mortality, longer lengths of ...
Detailed Description
This research study is designed to address these gaps by directly comparing the values of non-blinded, real-time and remotely monitored CGM data versus standard POC testing for hospital-based glucose ...
Eligibility Criteria
Inclusion
- ≥ 18 years of age
- English or Spanish speaker
- ≥ one of the following: diagnosis of type 2 diabetes documented in the EMR, or use of anti-hyperglycemic agent documented in the EMR, or serum or POC glucose \> 200 mg/dL in the first 24 hours of admission
Exclusion
- Anticipated LOS \< 24 hours
- Current or anticipated ICU placement
- Does not speak English or Spanish
- Known adhesive allergy
- Current participation in medication or device study
- Pregnant
- Any other condition that the PI Dr. Philis-Tsimikas or the attending physician deem contraindicated
Key Trial Info
Start Date :
February 25 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 17 2020
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT04269655
Start Date
February 25 2020
End Date
March 17 2020
Last Update
May 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Scripps Whittier Diabetes Institute
La Jolla, California, United States, 92037